GlassScriptPhysician profile
Sidney Morris Stoll
NPI 1770840167
$14,726.88
in general payments reported to CMS, 2019-2025
78 companies · $2,885 in 2025
The $2,885 reported for 2025 was more than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,575 · 2020: $2,514 · 2021: $550 · 2022: $1,016 · 2023: $1,486 · 2024: $2,701 · 2025: $2,885.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,852 · Education: $220.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,851.80 |
| Education | $220.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $1,048.38 | 2019-2025 | Opdivo, Opdualag, Augtyro |
| Astrazeneca Pharmaceuticals LP | $1,004.67 | 2019-2025 | Enhertu, Tagrisso, Calquence |
| Janssen Biotech, INC. | $989.08 | 2019-2025 | Rybrevant, Erleada, Balversa |
| Incyte Corporation | $936.24 | 2019-2025 | Jakafi, Monjuvi, Zynyz |
| Genentech USA, INC. | $841.26 | 2019-2025 | Venclexta, Tecentriq, Itovebi |
| Pfizer INC. | $790.96 | 2019-2025 | |
| Daiichi Sankyo INC. | $582.46 | 2019-2025 | Injectafer, Enhertu |
| Merck Sharp & Dohme LLC | $570.31 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Amgen INC. | $544.31 | 2019-2023 | Prolia, Evenity |
| Genzyme Corporation | $495.35 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $447.41 | 2019-2025 | Fruzaqla, Ninlaro |
| Novartis Pharmaceuticals Corporation | $445.64 | 2019-2025 | |
| Blueprint Medicines Corporation | $433.78 | 2020-2025 | Ayvakit |
| Karyopharm Therapeutics INC. | $315.78 | 2020-2024 | Xpovio |
| Celgene Corporation | $280.40 | 2019-2025 | Reblozyl, Opdualag, Breyanzi |
Show all 78 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $278.71 | 2019-2025 | |
| Astellas Pharma US INC | $271.89 | 2019-2025 | Vyloy, Padcev, Xospata |
| Glaxosmithkline, LLC. | $258.37 | 2020-2025 | Ojjaara, Jemperli, Blenrep |
| Eisai INC. | $252.15 | 2020-2025 | |
| Regeneron Healthcare Solutions, INC. | $235.60 | 2019-2024 | Libtayo |
| Lilly USA, LLC | $233.13 | 2019-2025 | Jaypirca, Verzenio, Retevmo |
| Alexion Pharmaceuticals, INC. | $213.49 | 2019-2025 | Ultomiris |
| Puma Biotechnology, INC. | $210.47 | 2019-2024 | |
| Mirati Therapeutics, INC. | $195.78 | 2023-2024 | Krazati |
| Pharmacyclics LLC, An Abbvie Company | $174.65 | 2019-2021 | |
| Dova Pharmaceuticals | $138.70 | 2019-2020 | |
| Stemline Therapeutics INC. | $129.20 | 2023-2025 | Orserdu |
| Kite Pharma, INC. | $121.78 | 2019 | |
| Tersera Therapeutics LLC | $117.29 | 2020-2025 | Zoladex |
| Clovis Oncology, INC. | $109.76 | 2019-2020 | |
| Abbvie INC. | $106.06 | 2024-2025 | |
| Taiho Oncology, INC. | $96.04 | 2020-2025 | |
| Tolmar Pharmaceuticals, INC. | $86.80 | 2019-2020 | |
| Pharmaessentia USA Corporation | $84.97 | 2023-2025 | Besremi |
| Secura Bio, INC. | $77.66 | 2019-2020 | |
| Array Biopharma INC | $76.71 | 2022-2024 | Braftovi, Lorbrena, Mektovi |
| Rigel Pharmaceuticals, INC. | $65.44 | 2019-2024 | Rezlidhia, Tavalisse |
| Emd Serono, INC. | $64.98 | 2019-2024 | |
| Tesaro, INC. | $62.64 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $61.56 | 2023-2025 | Onivyde, Somatuline Depot |
| Beigene USA, INC. | $60.85 | 2020-2024 | Tevimbra |
| Genmab U.S., INC. | $59.94 | 2025 | Epkinly |
| Organon LLC | $52.95 | 2024-2025 | Ontruzant |
| Tempus Ai, INC | $51.22 | 2025 | Xt Cdx |
| Seagen INC. | $51.01 | 2020-2021 | |
| Sun Pharmaceutical Industries INC. | $49.71 | 2020-2023 | Yonsa, Odomzo |
| Teva Pharmaceuticals USA, INC. | $47.89 | 2019 | |
| Helsinn Therapeutics (U.S.), INC. | $46.94 | 2019-2024 | Akynzeo |
| Exelixis INC. | $45.84 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $44.92 | 2019 | |
| Coherus Oncology, INC. | $44.90 | 2025 | Loqtorzi |
| Eusa Pharma (US) LLC | $42.51 | 2020-2022 | |
| Kyowa Kirin, INC. | $38.91 | 2019 | |
| Novocure INC. | $38.56 | 2020-2024 | Optune Lua (Novottf-200t) |
| Foundation Medicine, INC. | $37.86 | 2020-2023 | |
| Janssen Pharmaceuticals, INC | $32.85 | 2024 | Xarelto |
| Myriad Genetic Laboratories, INC. | $32.50 | 2024 | Myrisk |
| Gilead Sciences, INC. | $30.51 | 2021-2022 | |
| Apellis Pharmaceuticals, INC. | $29.82 | 2024 | Empaveli |
| Cti Biopharma Corp. | $29.70 | 2023 | Vonjo |
| Deciphera Pharmaceuticals INC. | $28.10 | 2024 | Qinlock |
| Spectrum Pharmaceuticals INC. | $27.92 | 2019 | |
| Sumitomo Pharma America, INC. | $26.96 | 2025 | Orgovyx |
| Adaptive Biotechnologies Corporation | $26.09 | 2024 | Clonoseq |
| Geron Corporation | $25.20 | 2025 | Rytelo |
| Beone Medicines USA, INC. | $24.82 | 2025 | Tevimbra |
| Immunogen, INC. | $24.64 | 2023 | Elahere |
| Immunomedics, INC. | $24.59 | 2020 | |
| Agios Pharmaceuticals, INC. | $23.55 | 2019 | |
| Caris Mpi, INC. | $22.95 | 2025 | Mi Cancer Seek |
| Adc Therapeutics America, INC. | $22.81 | 2024 | |
| Pharmaand Gmbh | $21.78 | 2025 | Rubraca |
| Tolmar, INC. | $21.62 | 2023 | |
| Verastem, INC. | $21.09 | 2019 | |
| Sobi, INC | $20.86 | 2024 | |
| Azurity Pharmaceuticals, INC. | $17.68 | 2025 | Danziten |
| Chiesi USA, INC. | $17.02 | 2021 | |
| Emmaus Medical, INC. | $9.95 | 2024 | Endari |
Drugs and devices associated with these payments
Enhertu $501Keytruda $488Rybrevant $304Opdivo $293Injectafer $253Ayvakit $236Jakafi $206Krazati $196Lynparza $174Erleada $172Reblozyl $168Xpovio $154Elrexfio $146Venclexta $138Orserdu $129Balversa $125Epkinly $125Akeega $121Vyloy $116Fruzaqla $107Lorbrena $107Braftovi $107Mektovi $107Ninlaro $103Lenvima $102Ibrance $100Welireg $96.16Xtandi $95.44Oxbryta $86.98Besremi $84.97Libtayo $83.14Talzenna $81.00Tecentriq $80.02Talvey $78.70Opdualag $78.03Orgovyx $76.21Adcetris $75.79Darzalex $68.83Verzenio $67.82Jaypirca $67.82Ojjaara $67.13Fabhalta $66.91Elahere $65.72Imbruvica $64.98Onivyde $61.56Lonsurf $60.44Inqovi $60.44Ultomiris $59.00Keytruda Qlex $58.83Stivarga $56.36Sarclisa $55.04Tagrisso $54.89Nubeqa $53.36Ontruzant $52.95Pluvicto $51.78Monjuvi $51.71Zynyz $51.71Xt Cdx $51.22Tevimbra $51.04Tecvayli $49.81Retevmo $46.17Loqtorzi $44.90Tukysa $39.96Prolia $36.42Evenity $36.42Zoladex $36.20Mekinist $36.14Calquence $36.07Jemperli $35.24Yonsa $33.05Odomzo $33.05Xarelto $32.85Myrisk $32.50Xalkori $31.95Inlyta $31.75Itovebi $31.06Wayrilz $30.81Padcev $30.60Blenrep $30.18Empaveli $29.82Comirnaty $29.79Vonjo $29.70Tivdak $28.81Elitek $28.79Qinlock $28.10Somatuline Depot $26.42Breyanzi $26.34Clonoseq $26.09Vitrakvi $25.85Optune Lua (Novottf-200t) $25.54Rytelo $25.20Akynzeo $23.55Mi Cancer Seek $22.95Rubraca $21.78Eligard $21.62Kisqali $21.21Synagis $20.86Kadcyla $19.06Perjeta $19.06Phesgo $19.06
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sidney Stoll listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.